Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020–2024
American Journal of Perinatology · 2026-10 · 43 (14) · 1947-1953
DOI: 10.1055/a-2849-7756 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 24.04.2026. Verfasst von Amna Umer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States. Hauptthemen laut MEDLINE: Gabapentin, Analgesics, Opioid. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
This study aimed to examine the association between prenatal gabapentin exposure, with and without opioid coexposure, and adverse perinatal outcomes. We conducted a retrospective, population-based cohort study of all live singleton births in West Virginia from January 2020 to July 2024 (n = 77,059). Exposure was categorized as no exposure to gabapentin or opioids, gabapentin alone, opioids alone, or both. Outcomes included birth weight, gestational age, 5-minute APGAR, low birth weight (LBW,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States.
- Department of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, Morgantown, West Virginia, United States.
- Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, Morgantown, West Virginia, United States.
- School of Medicine, West Virginia University, Morgantown, West Virginia, United States.
- Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
- Local Data Solutions, Morgantown, West Virginia, United States.
ORCID-Profile: Amna Umer
Zitieren
APA
Umer, A., Berry, J. H., Lilly, C., Davis, N., Ganoe, M., Lefeber, C., Breyel, J., John, C., & Najib, U. (2026). Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020–2024. American Journal of Perinatology, 43(14), 1947-1953. https://doi.org/10.1055/a-2849-7756
Vancouver
Umer A, Berry JH, Lilly C, Davis N, Ganoe M, Lefeber C, et al. Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020–2024. American Journal of Perinatology. 2026;43(14):1947-1953. doi:10.1055/a-2849-7756
BibTeX
@article{Umer2026,
author = {Umer, Amna and Berry, James H and Lilly, Christa and Davis, Nicholas and Ganoe, Maria and Lefeber, Candice and Breyel, Janine and John, Collin and Najib, Umer},
title = {Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020–2024},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {14},
pages = {1947--1953},
doi = {10.1055/a-2849-7756}
}
EUVIMED